Figure 2.
Mean Hb changes from baseline in nondialysis and dialysis patients. (A) Nondialysis patients. Mean Hb changes from baseline in the main phase 3 randomized clinical trials testing HIF-PHI compared with placebo or darbepoetin alfa. (B) Dialysis patients. Mean Hb changes from baseline in the main phase 3 randomized clinical trials testing HIF-PHI compared with ESA.